Cochlear Research Development from 2010 to 2026
| OC5 Stock | EUR 120.00 4.00 3.23% |
Research Development | First Reported 2010-12-31 | Previous Quarter 335.2 M | Current Value 225.6 M | Quarterly Volatility 60.4 M |
Check Cochlear financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cochlear's main balance sheet or income statement drivers, such as Tax Provision of 87.9 M, Net Interest Income of 845.2 K or Interest Income of 14.1 M, as well as many indicators such as . Cochlear financial statements analysis is a perfect complement when working with Cochlear Valuation or Volatility modules.
Cochlear | Research Development |
The Research Development trend for Cochlear Limited offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Cochlear is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Cochlear's Research Development Growth Pattern
Below is the plot of the Research Development of Cochlear Limited over the last few years. It is Cochlear's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cochlear's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Cochlear Research Development Regression Statistics
| Arithmetic Mean | 195,759,290 | |
| Geometric Mean | 188,043,099 | |
| Coefficient Of Variation | 30.84 | |
| Mean Deviation | 48,284,611 | |
| Median | 184,400,000 | |
| Standard Deviation | 60,372,117 | |
| Sample Variance | 3644.8T | |
| Range | 192.1M | |
| R-Value | 0.88 | |
| Mean Square Error | 897.9T | |
| R-Squared | 0.77 | |
| Slope | 10,484,300 | |
| Total Sum of Squares | 58316.7T |
Cochlear Research Development History
About Cochlear Financial Statements
Cochlear stakeholders use historical fundamental indicators, such as Cochlear's Research Development, to determine how well the company is positioned to perform in the future. Although Cochlear investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cochlear's assets and liabilities are reflected in the revenues and expenses on Cochlear's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cochlear Limited. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 335.2 M | 225.6 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Cochlear Stock
Cochlear financial ratios help investors to determine whether Cochlear Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cochlear with respect to the benefits of owning Cochlear security.